Pyrrolocarbazoles as checkpoint 1 kinase inhibitors

被引:28
作者
Henon, Helene [1 ]
Conchon, Elisabeth [1 ]
Hugon, Bernadette [1 ]
Messaoudi, Samir [1 ]
Golsteyn, Roy M. [2 ]
Prudhomme, Michelle [1 ]
机构
[1] Univ Blaise Pascal, CNRS, Lab SEESIB, UMR 6504, F-63177 Aubiere, France
[2] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada
关键词
checkpoint kinase 1; antitumor agents; pyrrolocarbazole; granulatimide;
D O I
10.2174/187152008785133100
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The carbazole framework is found in many natural compounds of biological interest. Indolocarbazoles such as rebeccamycin and staurosporine which are either a topoisomerase I inhibitor (rebeccamycin) or a non selective kinase inhibitor (staurosporine) are bacterial metabolites. In the search for new antitumor agents, DNA damage checkpoint kinases, in particular Checkpoint kinase 1, have recently emerged as attractive targets for cancer therapy. This review reports the synthesis and Chk1 inhibitory activities of pyrrolocarbazole compounds bearing four or five fused rings.
引用
收藏
页码:577 / 597
页数:21
相关论文
共 90 条
[1]  
Andersen R. J., 1999, Chem. Abstr., Patent No. [WO 9947522A1, 9947522, W099/47522, CA 131: 243451]
[2]  
Anderson Hilary J, 2003, Prog Cell Cycle Res, V5, P423
[3]   Synthesis of pyridino[3′,2′:4,5]pyrrolo[3,2-g]pyrrolo-[3,4-e]indolizin-1,3-dione and pyrrolo[3,2-c]pyrazole skeletons [J].
Anizon, F ;
Pfeiffer, B ;
Prudhomme, M .
TETRAHEDRON LETTERS, 2006, 47 (04) :433-436
[4]  
ARRINGTON KL, 2007, Patent No. 0275961
[5]  
ASHWELL S, 2007, Patent No. 0010556
[6]  
ASHWELL S, 2007, Patent No. 0149560
[7]  
ASHWELL S, 2007, P AM ASS CANC RES, V46
[8]   Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J].
Bao, Shideng ;
Wu, Qiulian ;
McLendon, Roger E. ;
Hao, Yueling ;
Shi, Qing ;
Hjelmeland, Anita B. ;
Dewhirst, Mark W. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
NATURE, 2006, 444 (7120) :756-760
[9]   DNA damage checkpoints: from initiation to recovery or adaptation [J].
Bartek, Jiri ;
Lukas, Jiri .
CURRENT OPINION IN CELL BIOLOGY, 2007, 19 (02) :238-245
[10]  
BENDER S, 2005, Patent No. 0038097